Dmg Group, LLC Merck & Co., Inc. Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dmg Group, LLC holds 13,138 shares of MRK stock, worth $1.31 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

13,138

Previous 13,535 2.93%

Holding current value

$1.31 Million

Previous $1.68 Million 10.99%

% of portfolio

1.23%

Previous 1.44%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $44,126 - $51,201	-397 Reduced 2.93%	13,138 $1.49 Million
Q2 2024 Jul 16, 2024	SELL	$123.8 - $132.96 $111,915 - $120,195	-904 Reduced 6.26%	13,535 $1.68 Million
Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $19,477 - $22,695	-172 Reduced 1.18%	14,439 $1.91 Million
Q4 2023 Jan 10, 2024	SELL	$100.18 - $109.02 $80,745 - $87,870	-806 Reduced 5.23%	14,611 $1.59 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $4,118 - $4,573	-40 Reduced 0.26%	15,417 $1.59 Million
Q2 2023 Jul 13, 2023	BUY	$108.61 - $118.38 $63,862 - $69,607	588 Added 3.95%	15,457 $1.78 Million
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $175,718 - $196,066	1,707 Added 12.97%	14,869 $1.62 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $30,778 - $39,462	352 Added 2.75%	13,162 $1.46 Million
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $33,220 - $37,319	393 Added 3.17%	12,810 $1.12 Million
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $177,833 - $201,583	2,130 Added 20.71%	12,417 $1.15 Million
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $15,584 - $17,468	-212 Reduced 2.02%	10,287 $870,000
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $758,867 - $950,579	10,499 New	10,499 $846,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account